Tuesday, December 6, 2005
28

Hepatitis B-Related Mortality in the United States, 1990-2001: Analysis of Multiple Cause-Coded Death Data

Helen W. Shih, Data Collection and Analysis/HIV Epidemiology, Los Angeles County Department of Health Services, 600 S. Commonwealth Ave. 19th Floor, Los Angeles, CA, USA


Learning Objectives for this Presentation:
By the end of the presentation participants will be able to understand the importance of hepatitis B as a cause of mortality in the United States and recognize the demographic groups at increased risk of dying from hepatitis B.

Background:
Hepatitis B virus (HBV) is a cause of substantial morbidity in the United States. However there is little information on HBV-associated comorbidities contributing to HBV deaths.

Methods:
Using multiple cause of death data, crude and age-adjusted mortality rates and 95% confidence intervals were calculated for age group, gender, racial/ethnic group and year. Possible HBV-related comorbid conditions were evaluated by matched comparison of HBV-related deaths to other deaths.

Results:
The overall age-adjusted HBV mortality rate was 0.72 (95% CL 0.71, 0.73) per 100,000 person-years over the 12-year period. The age-adjusted mortality rates were highest in males (3.3, 95% CL 3.2, 3.4) and Asians (3.6, 95% CL 3.5, 3.7) and Blacks (1.3, 95% CL1.24, 1.32). Foreign-born persons compromised 19.3% of the deaths. Among Asians, crude HBV mortality rates were highest in the individuals classified as Vietnamese (36.52, 95% CL 36.51, 36.52), Chinese (3.32, 95% CL 3.32, 3.33) and Korean (3.24, 95% CL 3.24, 3.25). Other viral hepatitis infections, primary hepatocellular carcinoma, HIV and other liver conditions were substantially more likely to be listed on HBV death records than non-HBV deaths.

Conclusions:
HBV is an important cause of preventable mortality in the U.S. Mortality rates are highest in males, Blacks, and Asians. Continued immunization efforts are necessary to reduce the burden of HBV mortality.

See more of Poster Session #1
See more of The 2005 National Viral Hepatitis Prevention Conference